We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$11.8B
AUM Growth
+$76M
Cap. Flow
-$34.6M
Cap. Flow %
-0.29%
Top 10 Hldgs %
11.39%
Holding
986
New
26
Increased
388
Reduced
338
Closed
13

Top Buys

Rank Stock Value
1
CFR icon
Cullen/Frost Bankers
CFR
+$45.7M
2
MEDP icon
Medpace
MEDP
+$45.2M
3
AIZ icon
Assurant
AIZ
+$29.9M
4
EPAC icon
Enerpac Tool Group
EPAC
+$23.9M
5
TILE icon
Interface
TILE
+$23.6M

Top Sells

Rank Stock Value
1
NSIT icon
Insight Enterprises
NSIT
+$29.6M
2
MANH icon
Manhattan Associates
MANH
+$23M
3
SYY icon
Sysco
SYY
+$21.4M
4
FIX icon
Comfort Systems
FIX
+$21.2M
5
PIPR icon
Piper Sandler
PIPR
+$19.7M

Sector Composition

Rank Sector Weight
1 Industrials 17.91%
2 Technology 17.69%
3 Healthcare 16.96%
4 Financials 14.09%
5 Consumer Discretionary 12.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMAB icon
901
Genmab
GMAB
$19.6B
$3K ﹤0.01%
140
+42
+43% +$923
HRI icon
902
Herc Holdings
HRI
$5.63B
$3K ﹤0.01%
18
-106
-85% -$21.4K
JHX icon
903
James Hardie Industries
JHX
$17.9B
$3K ﹤0.01%
105
PHG icon
904
Philips
PHG
$26.2B
$3K ﹤0.01%
112
+2
+2% +$52
PUK icon
905
Prudential
PUK
$34.2B
$3K ﹤0.01%
186
RL icon
906
Ralph Lauren
RL
$23.6B
$3K ﹤0.01%
14
ROL icon
907
Rollins
ROL
$17.6B
$3K ﹤0.01%
57
-1
-2% -$49
STLA icon
908
Stellantis
STLA
$20.2B
$3K ﹤0.01%
260
TECH icon
909
Bio-Techne
TECH
$11.3B
$3K ﹤0.01%
47
+7
+18% +$514
TRMB icon
910
Trimble
TRMB
$13.1B
$3K ﹤0.01%
44
UHS icon
911
Universal Health Services
UHS
$10.2B
$3K ﹤0.01%
14
+7
+100% +$1.43K
VOD icon
912
Vodafone
VOD
$37.2B
$3K ﹤0.01%
344
DAY
913
DELISTED
Dayforce
DAY
$3K ﹤0.01%
36
AEG icon
914
Aegon
AEG
$13.9B
$2K ﹤0.01%
418
ALLE icon
915
Allegion
ALLE
$14.1B
$2K ﹤0.01%
13
APA icon
916
APA Corp
APA
$14B
$2K ﹤0.01%
95
-116
-55% -$2.71K
BF.B icon
917
Brown-Forman Class B
BF.B
$12.8B
$2K ﹤0.01%
62
+37
+148% +$1.63K
DVA icon
918
DaVita
DVA
$11.6B
$2K ﹤0.01%
15
EMN icon
919
Eastman Chemical
EMN
$8.29B
$2K ﹤0.01%
19
-6
-24% -$615
ESLT icon
920
Elbit Systems
ESLT
$36.5B
$2K ﹤0.01%
8
FMS icon
921
Fresenius Medical Care
FMS
$12.6B
$2K ﹤0.01%
70
GRAB icon
922
Grab
GRAB
$14.7B
$2K ﹤0.01%
479
HSIC icon
923
Henry Schein
HSIC
$10.1B
$2K ﹤0.01%
26
-3
-10% -$215
ICL icon
924
ICL Group
ICL
$7.06B
$2K ﹤0.01%
314
IVZ icon
925
Invesco
IVZ
$13.9B
$2K ﹤0.01%
126

Similar funds

GW&K Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, GW&K Investment Management held 986 positions worth $11.8B, up 0.65% from $11.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4%. GW&K Investment Management opened 26 new positions and exited 13, leaving the 986-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • GW&K Investment Management's largest Q4 2024 buy was Cullen/Frost Bankers: 347,838 shares worth $46.7M.
  • GW&K Investment Management added most to Medpace in Q4 2024, an estimated $45.2M increase.
  • GW&K Investment Management's biggest Q4 2024 reduction was Insight Enterprises, cutting an estimated $29.6M.
  • GW&K Investment Management fully exited Insperity in Q4 2024, selling an estimated $8.17M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $11.8B portfolio in Q4 2024.
  • GW&K Investment Management opened 26 new positions and closed 13 in Q4 2024.
  • GW&K Investment Management's portfolio value rose 0.65% quarter-over-quarter to $11.8B.

Based on GW&K Investment Management's 13F filing for Q4 2024, filed 5 Feb 2025.